自体脂肪移植用于全乳再造的体积评估
多中心前瞻性BREAST试验将乳房切除术后女性随机分为自体脂肪移植(AFT)乳房再造或假体再造(IBR),用Vectra 3D成像在术后12个月比较体积。共148例(AFT 75例、IBR 73例)纳入分析,12个月时IBR组体积显著更优(83.8 ml,p < 0.001);AFT组12个月平均移植物存活率为37.1%,6至12个月间未下降。
要点
- AFT组12个月平均移植物存活率为37.1%,6至12个月间未下降。
- 12个月时IBR组体积较AFT组显著更优(83.8 ml,p < 0.001)。
- 移植物存活的显著影响因素包括胸围、合并症、年龄和总脂肪注射量。
核心结论
- 整形外科医生可仅用AFT为乳房切除术后患者再造较大体积的乳房,这些乳房体积在6个月时趋于稳定,且VECTRA 3D用于乳房体积测量可靠。
- 约三分之一的移植脂肪被计算为术后存活,再造外科医生应注意不要在一次手术中移植过多脂肪。
研究设计与样本
- 多中心前瞻性BREAST试验,将乳房切除术后女性随机分为AFT乳房再造组或IBR组。
- 共148例患者(AFT 75例、IBR 73例)纳入最终分析。
- 使用Vectra 3D成像系统评估体积,在术后12个月进行比较。
- 移植物存活定义为增加的体积除以脂肪填充体积。
- 使用多变量回归分析识别移植物存活的显著混杂因素。
主要发现
- 术后12个月体积在IBR组显著更优(83.8 ml,p < 0.001)。
- AFT组移植物存活在6至12个月间未下降,12个月平均移植物存活率为37.1%。
- 移植物存活的显著混杂因素包括胸围(β = 1.107,p = 0.001)、合并症(β = 28.567,p = 0.002)、年龄(β = -0.514,p = 0.007)和总脂肪填充量(β = -0.028,p < 0.001)。
临床怎么用
- 作者认为整形外科医生可仅用AFT为乳房切除术后患者再造较大体积的乳房。
- 作者指出约三分之一的移植脂肪被计算为术后存活,再造外科医生应注意不要在一次手术中移植过多脂肪。
- 作者认为VECTRA 3D用于乳房体积测量可靠。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Reconstructive surgeons have shifted from correcting contour irregularities using autologous fat transfer (AFT) toward reconstructing full breasts. Although several studies have researched the volumetric aspects of AFT, some outcomes such as volume retention, viability, and possible confounders for graft survival, remain unclear. This study aimed to answer these questions. METHODS: Post-mastectomy women of the multicenter prospective BREAST-trial were randomized to either AFT breast reconstruction or implant-based reconstruction (IBR). Volumes were assessed using the Vectra 3D imaging system and compared at 12 months post-operative. Volume retention was defined as the augmented volume divided by the lipofilling volume. Significant confounders for graft survival were identified using multivariable regression analysis. RESULTS: A total of 148 patients (75 AFT, 73 IBR) were included in the final analyses. Post-operative volumes differed significantly at 12 months in favor of the IBR group (83.8 ml, p < 0.001). For AFT patients, graft survival did not decrease between 6 and 12 months, with a mean graft survival of 37.1% at 12 months. Significant confounders for graft survival included chest circumference (β = 1.107, p = 0.001), comorbidities (β = 28.567, p = 0.002), age (β = -0.514, p = 0.007), and total lipofilling (β = -0.028, p < 0.001). CONCLUSION: Plastic surgeons can reconstruct voluminous breasts post-mastectomy using only AFT, and these breast volumes stabilize at 6 months and VECTRA 3D is reliable for breast volume measurement. Approximately a third of the grafted fat was calculated to survive post-operatively and reconstructive surgeons should be aware not to transfer too much fat in one session.
引用
- Wederfoort JLM, Trommelen DAX, Al Tarah M, et al. Volumetric evaluation of autologous fat transfer for total breast reconstruction. J Plast Reconstr Aesthet Surg. 2024. PMID: 39413587. doi:10.1016/j.bjps.2024.09.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。